Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding

Department of Microbiology, University of Pavia, Italy.
Sexually Transmitted Infections (Impact Factor: 3.08). 04/2004; 80(2):108-12. DOI: 10.1136/sti.2003.005157
Source: PubMed

ABSTRACT To link local proinflammatory cytokines with HIV related nucleic acids in cervico-vaginal secretions and the factors associated with them.
An observational study on 60 HIV positive women attending the department of obstetrics and gynaecology, University of Pavia, Italy. HIV-1 RNA in plasma, proviral HIV-1-DNA, cell associated and cell free HIV-1 RNA in cervico-vaginal secretions were evaluated by competitive polymerase chain reaction (c-PCR) and reverse transcriptase PCR (cRT-PCR). IL-1beta, IL-6, and TNF-alpha were measured by ELISA in cervico-vaginal lavages. Multiple regression analysis on ordinal categorical variables was used to test for the simultaneous associations of clinical and microbiological variables on quartiles of cytokine concentrations in lavage samples.
Proviral HIV-1 DNA, cell associated and cell free HIV-1 RNA were detected in 76.7% (46/60), 70% (42/60), and 71.7% (43/60) of the patients, respectively. IL-1beta concentration was directly correlated with proviral HIV-DNA (Spearman rho = 0.35, p = 0.01) and cell associated HIV-RNA levels (Spearman rho = 0.263, p = 0.05). IL-1beta concentration (153.9 pg/ml) was higher (p<0.05) among women with cytological squamous intraepithelial lesion (SIL) than negative controls (73.4 pg/ml). In women with vaginal infection both IL-1beta (41.7 pg/ml) and IL-6 (10.2 pg/ml) were lower (p<0.05) in comparison to negative controls (144.9 pg/ml and 23.7 pg/ml, respectively). Women receiving stable antiretroviral therapy had significantly lower TNF-alpha (34.4 pg/ml versus 44.4 pg/ml, p = 0.04) and higher IL-6 (24.0 pg/ml versus 1.4 pg/ml, p = 0.004) levels in lavage samples compared to untreated women. The associations between the presence of SIL, antiretroviral treatment, vaginal infection and cytokine concentrations in cervico-vaginal secretions were confirmed in multiple regression analysis.
Local immune activation may modulate HIV-1 shedding in cervico-vaginal secretion with possible influence on vaginal physiology and host defence. Pharmacological agents lowering HIV-1 replication cause a shift to a pattern of cytokine production which seems less favourable to the transmission of the disease.


Available from: Roberta Migliavacca, Jul 08, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Coherent drug/microbicide/vaccine development research would benefit through a precise knowledge of HIV dissemination and its persistence in the female genital tract. Understanding relationship between plasma viremia and cervicovaginal HIV shedding may help to unveil mechanisms underlying transmission, compartmentalization and pathogenesis. To study the association between HIV-1 RNA levels in the plasma and CVL specimens. Whole blood, plasma and CVL specimens were collected from 36 ART naïve HIV-1 seropositive women qualifying the study inclusion criteria. Absolute CD4 counts, plasma and CVL HIV-1 RNA levels were estimated using commercially available kits (BD MultiSET™ Kit, Becton Dickinson, US and Abbott RT, Abbott Molecular, Germany). Correlation between plasma and CVL viral load was estimated by the Spearman's rank correlation coefficient. Additionally, the correlation between CVL viral load and absolute CD4 counts was studied. HIV-1 viral load in the CVL specimens was successfully quantified using the Abbott RT. Twenty-seven of 36 women (75%) had detectable HIV-1 RNA levels in plasma and CVL specimens. The CVL viral load did not show any correlation with plasma viral load (ρ=0.281, p=0.096) and showed a 'moderate correlation' (ρ=-0.563, p=0.0004) with absolute CD4 counts. Albeit, the Abbott RT is designed for estimating plasma HIV-1 RNA levels, the study reports its use for estimating HIV-1 RNA levels in the CVL specimens as well. In accordance with the previous studies, our results suggest that plasma and CVL viral load are not correlated and plasma viremia might not solely predict cervico vaginal HIV shedding.
    Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 10/2013; Volume 58,(Issue 4 , December 2013):730-732. DOI:10.1016/j.jcv.2013.10.018 · 3.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: HIV-1 shedding from the female genital tract is associated with increased sexual and perinatal transmission, and has been broadly evaluated in cross-sectional studies. However, few longitudinal studies have evaluated how the immune microenvironment effects shedding.
    JAIDS Journal of Acquired Immune Deficiency Syndromes 09/2014; DOI:10.1097/QAI.0000000000000336 · 4.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In order to reveal the effect of turnings on explosion propagation, experiments were performed in three different pipes (single bend, U-shaped pipe and Z-shaped pipe). Flame and pressure transducers were used to track the velocity at the explosion front. When the pipes were filled with methane, the explosion strength was significantly enhanced due to the turbulence induced by increasing the number of turnings, while the flame speed (Sf) and peak overpressure (ΔPmax) increased dramatically. In addition, the strength of the explosion increased in violence as a function of the number of turnings. However, when the bend was without methane, the turnings weakened the strength of the explosion compared with the ordinary pipe, shown by the decrease in the values of ΔPmax and Sf. In addition, the propagation characteristics in a U-shaped pipe were similar to those in a Z-shaped pipe and the values of ΔPmax and Sf were also close. The results show that the explosion propagation characteristics largely depend on gas distribution in the pipes and the number of turnings. The different directions of the turnings had no effect.
    Mining Science and Technology (China) 05/2011; 21(3):365-369. DOI:10.1016/j.mstc.2011.05.006